
Tesla's problems, Eli Lilly's weight loss pill, and egg prices surge: Business news roundup
Plus, Novo Nordisk’s Ozempic successor disappointed Wall Street again
We may earn a commission from links on this page.
Start Slideshow
Start Slideshow

Advertisement
Previous Slide
Next Slide
2 / 12

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
Advertisement
“We feel that a product like an oral, orforglipron, could serve a significant amount of patients globally,” Eli Lilly CFO Lucas Montarce said Monday at the Leerink (SIVB) 2025 Global Healthcare Conference.
Advertisement
Previous Slide
Next Slide

Advertisement
Previous Slide
Next Slide

Advertisement
Previous Slide
Next Slide

Advertisement
Previous Slide
Next Slide
One of the biggest questions surrounding Elon Musk and President Donald Trump’s partnership is whether it will last. One of the president’s former, short-lived advisers has a clue.
Advertisement
Advertisement
Previous Slide
Next Slide

Brazil is doubling the amount of eggs it exports as the U.S. tackles shortages caused by bird flu.
Advertisement
The ABPA, a Brazilian industry group that represents egg and meat exporters, said it will be doubling international egg shipments, shipping out up to 35,000 tons in 2025, according to Bloomberg. Last year, it exported about 18,000 tons of eggs, and the new number is already 67% more than it forecast in December.
Advertisement
Previous Slide
Next Slide
8 / 12

Advertisement
Previous Slide
Next Slide

Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street for the second time.
Advertisement
The pharmaceutical giant, known for its blockbuster diabetes drug Ozempic, announced on Monday that patients taking its experimental diabetes and weight-loss drug, CagriSema, lost an average of 15.7% of their body weight after 68 weeks in a phase 3 clinical trial.
Advertisement
Previous Slide
Next Slide
Jason Robins, Chief Executive Officer of the sports betting company, breaks down how DraftKings is using AI to dominate March Madness and beyond
Advertisement
Previous Slide
Next Slide
The author of The Little Book of Bitcoin says Trump has no one in his orbit who likes him
Advertisement